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Abstract
The history of the Golgi complex now reaches its 100 year anniversary. Over the past several decades, tremendous effort
has gone into cataloguing Golgi resident proteins, measuring the lipid compositions of Golgi membranes, and in elucidating
the pathways by which proteins and lipids traffic through this unique organelle. Only in the past 8 years or so has
experimental scrutiny extended to the investigation of how lipids and proteins cooperate to endow the Golgi with its various
capabilities regarding protein/lipid transport and sorting. In this chapter we review some of the most recent advances in
deciphering the functional interfaces between lipids and proteins of the Golgi complex. ß 1998 Elsevier Science B.V. All
rights reserved.
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1. Introduction
The Golgi complex was originally described 100
years ago by Camillo Golgi on the basis of its char-
acteristic morphology. This organelle assumes a
structure that consists of a stack of four (or more)
cisternae with £attened centers and dilated rims [1].
The accumulation of evidence from many years of
research in a large number of laboratories identi¢es
the Golgi as a central station for both protein and
lipid sorting reactions in eukaryotic cells. It is appre-
ciated to play central roles in regulating the £ow of
membrane tra⁄c to the late stages of the secretory
and lysosomal pathways, and in regulating the recy-
cling of membrane internalized from the cell surface.
Moreover, the Golgi complex experiences dynamic
involvements with both endosomal and endoplasmic
reticulum membranes. As such, the Golgi is subjected
to a continuous and massive in£ux of protein and
lipid from other cellular compartments. The fact
that Golgi membranes maintain their unique bio-
chemical and morphological identity in the face of
such membrane £ux serves as a remarkable testi-
mony to the e¡ectiveness of the protein and lipid
sorting mechanisms that eukaryotic cells possess.
Considerable e¡ort has been directed over recent
years at studying the mechanisms of protein trans-
port through the Golgi complex [2,3], and at describ-
ing the general form of lipid transport pathways that
employ Golgi membranes as a transit station [4]. Yet,
only now are we beginning to understand how the
protein and lipid components of the Golgi complex
might cooperate in a complex interplay of biochem-
ical reactions to promote Golgi secretory and sorting
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functions. While the detailed mechanisms for how
such a cooperation is accomplished remain largely
unelucidated, some general concepts are emerg-
ing. In this chapter, we provide a general review
of how the lipid composition of Golgi membranes
might be regulated, and how the lipid metabolic
pathways within Golgi membranes are intimately
related to the ability of the Golgi complex to func-
tion as a secretory organelle and protein sorting
station.
2. Phospholipid biosynthetic capabilities of Golgi
membranes
The bulk of glycerophospholipid and sterol bio-
synthesis is localized to membranes of the endoplas-
mic reticulum, mitochondria and peroxisomes [5,6].
However, the Golgi complex represents a major site
of sphingolipid synthesis in both mammalian cells
and in yeast. Since, as reviewed below, both the
mammalian and the yeast sphingolipid pathways rep-
resent potent diacylglycerol (DAG) generating ma-
chines, this aspect of Golgi biochemistry represents
an important interface between lipid biosynthesis and
Golgi function.
Sphingolipids represent ceramide-based lipids, and
the precursor ceramide (Cer) is produced in the en-
doplasmic reticulum. From there Cer is transported
to the Golgi complex where it is utilized in the bio-
synthesis of glucosylceramide (GlcCer) or sphingo-
myelin (SM). GlcCer synthesis is catalyzed on the
surface of cis- and medial-Golgi membranes by the
enzyme UDP-glucose:ceramide glucosyltransferase
[7]. At this point, GlcCer can be mobilized to the
plasma membrane (see below), or translocated (i.e.
£ipped) to the lumenal lea£et of Golgi membranes
where galactosylation of the headgroup to form lac-
tosylceramide (LacCer) occurs [8]. Sequential glyco-
sylation of LacCer by glycosyltransferases of the
Golgi lumen generates the familiar series of complex
glycolipids and gangliosides.
SM synthesis is driven by the enzyme SM-synthase
on cis- and medial-Golgi membranes although, in
contrast to the topology of GlcCer synthesis, on
the lumenal lea£ets of these membranes [9]. As
shown in Fig. 1, SM-synthase operates a headgroup
exchange reaction where phosphorylcholine is di-
rectly transferred from phosphatidylcholine (PtdCho)
to Cer with the concomitant release of diacylglycerol
(DAG). This mechanism for SM synthesis is of ex-
treme interest because it couples consumption of the
signaling lipid ceramide with production of the sig-
naling lipid DAG. This reaction can operate in re-
verse so that PtdCho and Cer are generated at the
expense of SM and DAG. Since SM has been esti-
mated to account for as much as 12% of the total
Golgi lipid [10], SM-synthase is suggested to impose
a very signi¢cant DAG load onto Golgi membranes
[11]. In a remarkably prescient discussion of the im-
plications of this biochemistry, Richard Pagano sug-
gested that this DAG load could be reduced either
by: (i) mobilizing the lipid from Golgi membranes
(by any one of several mechanisms), (ii) by subjecting
the DAG to metabolism by lipases, or (iii) by con-
sumption of Golgi DAG into PtdCho biosynthesis
Fig. 1. Sphingolipid synthesis in mammalian and yeast Golgi
membranes. Ceramide (Cer) is transported to the mammalian
Golgi complex where it is either converted to sphingomyelin
(SM) via a headgroup exchange reaction that consumes one
molecule of Cer and PtdCho for each molecule of SM and di-
acylglycerol (DAG) produced [9,11], or to glucosylceramide
(GlcCer). GlcCer is the precursor for synthesis of higher order
glycosphingolipids such as lactosylceramide (LacCer). In yeast,
ceramide is decorated with inositolphosphate, donated by
PtdIns, in the endoplasmic reticulum (ER). Inositolphosphocer-
amide (IPC) is transported to the Golgi complex where it can
be mannosylated with accompanying consumption of an acti-
vated sugar nucleotide to form MIPC. Finally, this sphingolipid
form can be inositolphosphorylated yet one more time to gener-
ate the most highly modi¢ed yeast sphingolipid, M(IP)2C. The
two inositolphosphorylation reactions each consume one mole-
cule of PtdIns and release one molecule of DAG. Thus, forma-
tion of M(IP)2C liberates two molecules of DAG: one in ER
membranes and one in Golgi membranes [13].
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via the CDP-choline pathway [11]. In support of (iii),
mammalian Golgi membranes do exhibit the capa-
bility to execute PtdCho synthesis via the CDP-chol-
ine pathway [12]. While the discussion by Pagano
focused on mechanisms of DAG removal from Golgi
membranes, and did not address the possible func-
tional consequences associated with Golgi DAG pro-
duction, recent work now sheds new light on this
problem (see Sections 4 and 5 below).
Yeast also synthesize sphingolipids, although these
cells do not synthesize SM. By contrast, yeast sphin-
golipids are inositolphosphoceramides whose biosyn-
thesis produces DAG both in endoplasmic reticulum
and in Golgi membranes [13]. As shown in Fig. 1,
these DAG molecules are produced by hydrolysis of
phosphatidylinositol (PtdIns) whose headgroup is
employed in modi¢cation of Cer to inositolphospho-
ceramide (IPC), and mannosylinositolphosphocer-
amide (MIPC) to mannosyldiinositolphosphocera-
mide (M(IP)2C). This sphingolipid pathway appears
to be intimately interfaced with a DAG-dependent
Golgi secretory vesicle budding reaction and the
competing CDP-choline pathway for PtdCho biosyn-
thesis (see Section 3). As in mammalian cells, there is
now strong evidence that yeast Golgi membranes are
also able to synthesize PtdCho via the CDP-choline
pathway [13^16].
3. Lipid tra⁄cking pathways that involve Golgi
membranes
Lipid tra⁄cking pathways can be classi¢ed into
two general modes: vesicular and non-vesicular.
The vesicular mechanism can be subdivided into con-
ventional and non-conventional modes depending on
whether the kinetic and biochemical properties con-
form to those determined for protein transport mech-
anisms that involve vesicles of the secretory or endo-
cytic pathways (i.e. conventional), or not (non-
conventional). The non-vesicular mechanism poten-
tially includes both the lipid transfer protein-medi-
ated mobilization of lipid monomers between distinct
membrane bilayers [5,6], and the exchange of lipids
between membranes that occurs as a result of inter-
organelle ‘collisions’. The subject of lipid transport
mechanisms has been treated in excellent detail in
several recent reviews [4^6,17] and will not be de-
scribed in similar detail here. However, convention-
al vesicular modes of lipid tra⁄cking appear to
play important roles in sustaining several aspects
of phospholipid, particularly sphingolipid, metab-
olism in Golgi membranes. As sphingolipid metab-
olism likely plays a critical role in promoting Golgi
function itself [9,11], examples of these are described
here.
3.1. Conventional vesicular pathways for lipid
tra⁄cking through the Golgi complex
There presently exist several in vitro examples of
lipid tra⁄cking through the Golgi stack that has
been interpreted to occur via conventional transport
vesicle route. One such line of evidence comes from
studies of reconstituted transport of LacCer from a
donor Golgi preparation to acceptor Golgi mem-
branes that had the capability to e¡ect a sialylation
of LacCer to ganglioside GM3. The readout from
such an assay is incorporation of labeled sialic acid
into GM3 and, by various operational criteria, this
assay has been interpreted to reconstitute the forma-
tion of protein transport vesicles [18]. The conclusion
that transport of secretory protein cargo and lacto-
sylceramide is realized via the same vesicular carriers
stems from the demonstration that both sets of cargo
exhibit the same kinetic transport parameters, are
equally inhibited by the biosynthetic protein trans-
port inhibitor GTPQS, and exhibit the same require-
ments for the NEM-sensitive factor that is required
for consumption of Golgi-derived protein transport
vesicles at the target Golgi membrane [18]. Quanti-
tation of the LacCer transport reaction indicates that
this conventional vesicular transport mode accounts
for the bulk, if not for the entirety, of the reconsti-
tuted movement of this sphingolipid between Golgi
compartments [18].
Second, a complementary set of data has also been
forthcoming from pharmacological studies. Measure-
ments of ganglioside biosynthesis were undertaken
under conditions where conventional secretory path-
way function had been disrupted at the level of the
Golgi complex, either by monensin or vinblastine
challenge, or by a low temperature (15‡C) block.
These studies demonstrated that blockage of ante-
rograde secretory pathway activity results in the ac-
cumulation of the ganglioside precursor GlcCer, and
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in a marked and concomitant reduction in the bio-
synthesis of more highly modi¢ed glycolipids and
gangliosides [19]. The conclusion from these studies
was that GlcCer is synthesized in the endoplasmic
reticulum, and that further modi¢cation of this phos-
pholipid into the more highly modi¢ed glycolipids/
gangliosides requires transport of GlcCer to the Gol-
gi complex by the same conventional vesicular car-
riers that ferry secretory glycoproteins [19]. Yet, as
noted above, the best data indicate that GlcCer is
synthesized on the cytosolic surface of Golgi mem-
branes ([9] ; see above). This location of biosynthesis
is not incompatible with the stated conclusion, how-
ever. Rather, it suggests that the GlcCer must
be transported by conventional vesicles not from
the endoplasmic reticulum, but from ‘early’ Gol-
gi compartments, to the appropriate Golgi cister-
nae.
Third, in an in vivo study, it has been demon-
strated that the synthesis of higher order yeast sphin-
golipids (i.e. MIPC and M(IP)2C), is highly sensitive
to interruption of vesicle-mediated transport of secre-
tory glycoprotein cargo from the endoplasmic retic-
ulum to the Golgi complex [13]. Biosynthesis of these
inositol sphingolipids is refractory to defects in late-
Golgi and post-Golgi secretory pathway function,
however [13]. These collective data have also been
interpreted to indicate that some precursor of
MIPC and M(IP)2C, perhaps inositolphosphocera-
mide or the phosphoinositol donor phosphatidylino-
sitol (PtdIns), must be delivered from the ER to the
Golgi via a vesicular carrier that also is involved in
biosynthetic secretory protein transport [13]. Thus, as
described in Fig. 1, the Golgi complex appears to
represent the intracellular site of M(IP)2C synthesis,
and continual delivery of membrane components
from the endoplasmic reticulum is required to sustain
the synthesis of more complex yeast sphingolipids.
Finally, the use of £uorescently labeled short acyl
chain derivatives of both sphingolipids and glycero-
phospholipids (i.e. the C6-NBD and C6-BODIPY de-
rivatives [4,20]) has permitted a detailed kinetic anal-
ysis of the intracellular itineraries of various lipid
tra⁄cking systems from the extracellular lea£et of
the plasma membrane of living cells. Evidence to
indicate a conventional vesicular mechanism has
been obtained with such reagents in the recycling
of phosphatidylcholine (PtdCho) and sphingolipids
from the plasma membrane to what is presumably
the lumenal lea£et of the Golgi, and back. In the case
of NBD-sphingolipids, NBD-Cer is incorporated
into the extracellular lea£et of the plasma membrane
of cells, is subsequently internalized, and ultimately
concentrates in the Golgi as NBD-GlcCer and NBD-
SM [21]. The latter phospholipid is presumably
formed by the headgroup exchange reaction illus-
trated in Fig. 1 that consumes one molecule of Cer
and produces one molecule of DAG. In both cases,
once the NBD-lipid accumulates in the Golgi, its
reappearance at the cell surface has been analyzed
with regard to its pharmacological, biochemical,
and kinetic parameters. Movement of lipid from
the Golgi to the plasma membrane exhibits a t1=2
of 20 min and is ATP-dependent [4^6, 17]. Both of
these properties conform to those associated with
tra⁄cking via conventional vesicles.
3.2. Sphingolipid rafts and protein sorting
Various analyses have indicated that SM and chol-
esterol concentrations increase in the cis- to trans-
Golgi direction [6,22]. In addition, glycosphingolip-
ids are preferentially sorted from the Golgi complex
into the apical plasma membranes of polarized epi-
thelial cells relative to PtdCho or SM [23]. This pol-
arized glycosphingolipid sorting is accompanied by
polarized sorting of glycosyl-PtdIns anchored pro-
teins and their assembly into Triton X-100-insoluble
structures that have been proposed to represent lipid
microdomains [24]. Based on these sorts of data, it
has been proposed that such glycosphingolipid mi-
crodomains, or rafts, spontaneously form via lateral
lipid-lipid associations in the lumenal lea£et of Golgi
membranes. The physical properties of the rafts are
such that proteins with speci¢c properties (e.g. GPI-
anchored proteins with two saturated fatty acyl
chains in the anchor structure, transmembrane pro-
teins, doubly acylated proteins, etc.) physically par-
tition into these microdomains and are thereby en-
riched in lipid structures that sort preferentially to
the apical plasma membrane. In this manner, the
ability of Golgi to drive glycosphingolipid synthesis
has been proposed to contribute to its function as a
sorting station [25]. What is attractive about this
proposal is that it represents one of the ¢rst concep-
tual attempts to integrate both lipid and protein bio-
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chemistry into a coherent description of an impor-
tant Golgi function. The body of evidence that
speaks directly to whether lipid rafts truly play phys-
iologically important sorting roles in vivo remains
somewhat meager, although emerging views on cav-
eolae function in mammalian plasma membrane are
largely consistent with the main tenets of the lipid
raft hypothesis [25]. The issue of Golgi lipid micro-
domains contributing to mechanisms of protein sort-
ing and retention are detailed in the chapter au-
thored by Nilsson (this volume).
3.3. A phospholipid transfer protein-mediated pathway
for lipid transport from the Golgi complex?
It is likely that some phospholipids tra⁄c through
or from the Golgi complex via transport modes that
do not involve vesicular carriers, however. Van Hel-
voort and colleagues have recently reported that C6-
NBD-glucosylceramide can tra⁄c from the cytoplas-
mic lea£et of Golgi membranes to the cytosolic leaf-
let of the plasma membrane via a kinetically rapid
pathway that is not perturbed by pharmacological
treatments that e¡ectively block tra⁄cking of con-
ventional vesicles from the Golgi complex to the
plasma membrane [26]. One interpretation of those
data is that the derivatized glucosylceramide is trans-
ported through the cytosol, as a monomer, by a
phospholipid transfer protein. The hallmark opera-
tional characteristic of phospholipid transfer proteins
is that these catalyze the energy-independent transfer
of phospholipids, as monomers, between membrane
bilayers in vitro [27,28]. While the physiological con-
sequences associated with a potential transfer pro-
tein-mediated transport mechanism for glucosylcera-
mide are unknown, and it remains to be established
that such a transport pathway indeed exists, it has
now been established that speci¢c phospholipid
transfer proteins play previously unappreciated roles
in regulating the interface between phospholipid me-
tabolism and Golgi function. In particular, it had
been proposed that a speci¢c yeast phospholipid
transfer protein may function in a phospholipid
transport reaction that remodels Golgi membrane
phospholipid composition [14,15]. This subject is
treated in greater detail below.
4. Interplay between lipid metabolism and Golgi
function
4.1. Introduction to PITPs
PITPs are phospholipid transfer proteins that cat-
alyze exchange of either PtdIns or PtdCho between
membrane bilayers in vitro with PtdIns representing
the preferred ligand in the exchange reaction [27,28].
In part because of this property, it has been widely
speculated that PITPs are involved in interorganellar
phospholipid transport reactions in vivo, and that
PtdIns binding/transfer represents the crucial physio-
logical activity. The PtdCho binding/transfer compo-
nent has received much less consideration, and one
of the extant puzzles surrounding PITPs revolves
around why these two phospholipid binding/transfer
activities have been co-conserved, particularly since
there is no obligate coupling between these two in the
context of phospholipid transfer assays in vitro [29].
However, of direct interest to the subject of this
chapter is the entirely unanticipated function of at
least one yeast PITP in regulating phospholipid me-
tabolism in Golgi membranes. This regulation is crit-
ical for the maintenance of appropriately high con-
centrations of a particular lipid in Golgi membranes
so that an essential Golgi-mediated secretory
function can be sustained. Moreover, mammalian
PITPs have also been implicated in the phosphoino-
sitide-mediated regulation of Golgi secretory func-
tion.
PITPs are of additional interest in that these ex-
hibit a high level of primary sequence conservation
[27]. This structural conservation among PITPs falls
into two distinct branches. PITPs of mammalian,
amphibian, and insect origin are all approx. 35
kDa in molecular weight and are recognized by poly-
clonal antisera raised against rat PITP [30]. Fungal
PITPs are also approx. 35 kDa in molecular mass,
and are highly similar to each other at the primary
sequence level [31^34]. Members of this family, how-
ever, all share signi¢cant primary homology with the
mammalian retinaldehyde binding protein (approx.
29% identity [33]). However, these proteins share
no primary sequence similarity with mammalian
PITPs [30,31].
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4.2. PITPs and yeast Golgi function
The Saccharomyces cerevisiae SEC14 gene product
(Sec14p) represents the major PITP of this organism
and it plays an essential role in protein exit from the
yeast Golgi complex [31,32]. While the precise
Sec14p execution point has not been unambiguously
determined, Sec14p de¢ciency is considered, by var-
ious operational criteria, to manifest itself as a defect
in the genesis of Golgi-derived secretory vesicles
[14,35,36]. A mechanistic dissection of how Sec14p
translates its PtdIns/PtdCho exchange activity to bio-
logical function has bene¢ted tremendously from the
application of genetic approaches.
Of key importance to the elucidation of Sec14p
function was the demonstration of mutations in at
least seven genes that relieve cells of the normally
essential Sec14p requirement for Golgi function and
cell viability [14,37,38]. The various data collected
from characterization of these ‘bypass Sec14p’ muta-
tions have been incorporated into a unifying pro-
posal that Sec14p maintains the integrity of a critical
Golgi diacylglycerol (DAG) pool that is required for
Golgi secretory function ([39]; Fig. 2). We term the
regulatory circuit by which Sec14p controls Golgi
membrane DAG levels, and by which DAG controls
formation of yeast Golgi-derived secretory vesicles,
as the ‘Sec14p pathway’. Its general form is depicted
in Fig. 2. In this regard, work from mammalian sys-
tems has also implicated a role for DAG in stimulat-
ing vesicle budding events at the level of the TGN
[40,41].
A central tenet of the DAG hypothesis as it relates
to yeast is that the PtdCho-bound form of Sec14p
represses activity of the CDP-choline pathway for
PtdCho biosynthesis in yeast Golgi membranes
[15,42]. Data to support this central concept include:
(i) the demonstration that inactivation of the CDP-
choline pathway for PtdCho biosynthesis (a potent
DAG consumer) elicits a ‘bypass Sec14p’ phenotype
[14], and (ii) that PtdCho-bound Sec14p inhibits
yeast cholinephosphate cytidylyltransferase (CCTase,
the rate-determining enzyme of the CDP-choline
pathway [42]; Fig 2). One implication of this pro-
posal is that the in vitro phospholipid exchange ac-
tivities of Sec14p represent a molecular switch
through which this PITP regulates a negative e¡ector
activity.
The PtdIns-bound form of Sec14p potentially
functions in increasing the rate of Golgi PtdIns me-
tabolism so that the Golgi DAG pool is replenished
(Fig 2). Data to support this suggestion include: (i)
the ¢nding that accelerated PtdIns turnover e¡ects
‘bypass Sec14p’ [39,43], (ii) the demonstration that
PtdIns transfer activity of mammalian PITP ex-
pressed in yeast is required for phenotypic rescue
of Sec14p defects [29], and (iii) that Sec14p stimu-
lates PtdIns metabolism in permeabilized cell recon-
stitutions of several phosphoinositide-dependent re-
actions [44,45]. Of particular interest with regard to
(i) is that elevated £ux through the yeast sphingolipid
biosynthetic pathway, which represents a potent Gol-
gi DAG-generating machine (Fig. 1), is su⁄cient to
e¡ect ‘bypass Sec14p’ [39]. Thus, the current picture
for how Sec14p functions invokes independent, yet
complementary, roles for the PtdCho- and PtdIns-
bound forms of the protein that converge on preser-
vation of a phospholipid precursor pool in Golgi
membranes. An important corollary of this model
Fig. 2. Sec14p regulates DAG levels in yeast Golgi membranes.
Sec14p inhibits DAG consumption by repressing activity of the
CDP-choline pathway for PC biosynthesis. Sec14p may poten-
tially facilitate DAG formation in Golgi membranes by stimu-
lating inositol phospholipid metabolism. Additional DAG might
be generated via the yeast sphingolipid biosynthetic pathway or
via phosphatidic acid phosphohydrolase (PtdOH hydrolase) ac-
tivity. Two candidate downstream regulators of the Sec14p
pathway that may respond to DAG are the BSD1 and KES1
gene products, positive (+) and negative (3) e¡ectors of the
Sec14p pathway for secretory vesicle genesis, respectively. Cho,
choline; ChoVP, phosphorylcholine; CKIase, choline kinase;
CCTase, cholinephosphate cytidylyltransferase; CPTase, cho-
linephosphotransferase.
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is that the hallmark in vitro PtdIns/PtdCho exchange
activity measured for Sec14p, and indeed all PITPs,
is subject to multiple interpretations, including those
that do not involve phospholipid transport.
One of the other major unresolved issues that still
remains is which of the liganded forms of Sec14p is
predominantly responsible for function. As indicated
above, speculations have almost exclusively focused
on PtdIns binding/transfer. In that regard, the crystal
structure of Sec14p has recently been solved to a
resolution of 2.5 Aî . Structure-based mutagenesis
data have now identi¢ed several Sec14p residues
that play critical and speci¢c roles in mediating
PtdIns, but not PtdCho, binding/transfer by Sec14p
[46]. These new data now permit the biological test
of whether PtdIns binding/transfer is essential for the
physiological function of Sec14p.
4.3. Speculations on the interface between lipid
metabolism and Golgi secretory function
The current model for Sec14p function in yeast
provides a remarkable revisitation of the question
posed by Richard Pagano [11] some 10 years ago,
i.e. what is the fate of Golgi DAG that is created
by sphingolipid biosynthesis? In yeast, experimental
data now permit us to entertain some general possi-
bilities. As in mammalian cells, sphingolipid biosyn-
thesis in yeast represents a potent Golgi DAG gen-
erating machine, even though the structure of the
sphingolipids themselves and the biochemical reac-
tions that generate them are fundamentally di¡erent
(see Fig. 1 above). We speculate that the DAG gen-
erated by modi¢cation of MIPC to M(IP)2C in the
yeast Golgi complex contributes to the Sec14p-re-
sponsive DAG pool, and that this DAG now is sub-
ject to two fates (Fig. 2). The ¢rst fate is to be em-
ployed as a signaling molecule in the secretory vesicle
biogenetic pathway, and that this role for DAG is an
essential one. The competing fate is to be consumed
as a phospholipid precursor in housekeeping phos-
pholipid biosynthesis, speci¢cally into PtdCho bio-
synthesis via the CDP-choline pathway. Obviously,
an appropriate balance between these two fates
must be struck, and Sec14p functions as the critical
regulator that maintains this balance (Fig. 2).
What then might the purpose of PtdCho synthesis
in yeast Golgi membranes be? We speculate that
perhaps it functions as the major sink for excess
Golgi DAG, and thereby allows for imposition of a
regulation of a speci¢c vesicle genesis cycle. This may
be especially important in yeast because there is no
evidence, to our knowledge, of a yeast DAG-kinase
activity that could scavenge DAG to phosphatidic
acid. Potential roles for acyl chain-directed lipases
in DAG turnover remain to be investigated.
How might DAG promote Golgi secretory func-
tion in yeast? First, it might serve as a precursor for
the signaling phospholipid phosphatidic acid
(PtdOH), the lack of evidence for a yeast DAG kin-
ase notwithstanding. This is not the case as high-level
expression of Escherichia coli DAG-kinase in yeast
both exacerbates Sec14p defects and neutralizes the
ability of elevated £ux through the yeast sphingolipid
pathway to e¡ect ‘bypass Sec14’ [39]. Two other al-
ternatives can be considered. First, by virtue of the
fact that DAG elaborates a small, uncharged head-
group, this lipid is able to spontaneously £ip-£op
between the lumenal and cytoplasmic lea£ets of
membrane bilayers [47]. As a result, DAG microdo-
mains could potentially play an important structural
role in imparting a plasticity to Golgi membranes
that facilitate the sorts of membrane deformation
reactions that accompany vesicle budding events.
The available data and technology do not yet permit
a critical evaluation of this possibility in the context
of a physiologically relevant experiment.
Alternatively, DAG might serve as a signaling lip-
id that is bound by an as yet unidenti¢ed polypep-
tide, and that such a protein-lipid interaction pro-
motes Golgi-derived secretory vesicle formation
(Fig. 2). We presently favor this signaling mode of
action because defects in a yeast oxysterol binding
protein homolog, Kes1p, seemingly render secretory
function independent of the state of the Golgi DAG
pool [48]. The reciprocal case also holds true. Kes1p
overexpression reimposes Golgi secretory dysfunc-
tion on Sec14p-de¢cient yeast strains whose viability
and Golgi secretory capability is normally Sec14p-
independent because of altered DAG metabolism
[48]. The indication that secretory vesicle genesis
can apparently be uncoupled from a normally essen-
tial Golgi DAG pool suggests that this DAG pool
plays a signaling, and not a structural, role in pro-
moting vesicle genesis. These data also identify
Kes1p as a potential DAG sensor.
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5. Phosphoinositides and Golgi function
It was noted some 40 years ago that treatment of
exocrine pancreas with secretagogues resulted in an
increased turnover of PtdIns and phosphoinositides
[49]. Those ¢ndings, when coupled with the more
recent demonstration that the ATP requirement for
Ca2-regulated exocytosis in permeabilized adrenal
chroma⁄n cells was partly accounted for by a re-
quirement for PIP2 synthesis [50], provided the ¢rst
evidence linking phosphoinositide metabolism with
vesicle tra⁄cking. As this burgeoning area has been
the subject of a recent and outstanding review [51],
we restrict the bulk of our attention to those areas
where phosphoinositide metabolism intersects with
Golgi function.
5.1. Mammalian PITPs and a role for
phosphoinositide synthesis in secretory function
Two distinct mammalian PITPs (PITPK and
PITPL) have been described, and these share 77%
primary sequence identity [52,53]. PITPL is further
distinguished from PITPK in that it catalyzes the
transfer of PI, PC and the ceramide-based phospho-
lipid SM between membrane bilayers in vitro. PITPK
has been identi¢ed in reconstitution assays as a cy-
tosolic factor that is required for Ca2-activated dis-
charge of secretory granule cargo in permeabilized
neuroendocrine cells [44], the budding of both con-
stitutive secretory vesicles and immature secretory
granules from the trans-Golgi network (TGN) of
neuroendocrine cells [54], and for the plasma mem-
brane receptor/G-protein-coupled hydrolysis of PIP2
mediated by phospholipase C (PLC) isoforms [45].
The former two reconstitution systems suggest a
physiological role for mammalian PITP in the regu-
lation of vesicle tra⁄cking. The notion that Sec14p/
PITP function is conserved between yeast and mam-
mals is further supported by the ¢ndings that the
ability of high-level expression of mammalian PITPK
and PITPL to rescue the growth and secretory de-
fects associated with Sec14p dysfunction in yeast
[52,55], and that Sec14p serves as an e¡ective surro-
gate for PITP in each of these PITP-dependent re-
constitutions [45,53,56].
What is the mechanism of PITP function in the
reconstituted reactions that exhibit PITP depend-
ence? In the reconstituted regulated secretion assay,
PITPK speci¢cally cooperates with a type I PtdIns-4-
phosphate 5-kinase to prepare (i.e. prime) dense core
secretory granules for Ca2-regulated exocytosis,
most likely by catalyzing synthesis of a PtdIns-4,5-
bisphosphate (PIP2) ‘domain’. A PIP2 ‘domain’ is
probably the functional entity required for secretory
granule fusion since challenge of primed membranes
with PtdIns-PLC deprimes the system [56]. At
present, a reasonable speculation is that this PIP2
domain (which may be situated on the cytoplasmic
lea£et of the secretory granule) acts as a binding sur-
face for a speci¢c PIP2 binding protein that itself
functions in the exocytic pathway. A strong candi-
date for just such a polypeptide, CAPS145, has been
identi¢ed and characterized [57].
How might PITPs regulate PIP2 pools? One body
of evidence obtained from permeabilized mammalian
cell systems suggests that PITPs physically interact
with PtdIns-4 kinases and act to present PtdIns to
them [58]. This concept posits that the signaling pool
of PIP2 is synthesized on demand, and that this
phosphoinositide pool does not exist prior to the
initial ‘signaling’ event. Such a mechanism is attrac-
tive in that it accounts for the long-standing conun-
drum as to why stimulation of phosphoinositide sig-
naling cascades results in ready detection of
phosphoinositide turnover products (e.g. DAG and
IP3), even though cellular PIP2 pools do not change
[59]. Other data do not support this idea, however.
Similar studies with turkey erythrocytes indicate that
PITPK does not act catalytically to stimulate phos-
phoinositide synthesis [60]. Rather, the data indicate
that PITPK merely plays a PtdIns supply role.
Clearly, it remains to be resolved whether the exper-
imental incongruencies represent authentic di¡eren-
ces between the experimental systems employed, or
whether there is some other explanation. We note
that it has been reported that deletion of the ¢ve
C-terminal residues of PITPK eliminates the ability
of this protein to stimulate phosphoinositide synthe-
sis, even though this deletion has only modest e¡ects
on PtdIns transfer activity of PITPK [61]. This result
is di⁄cult to reconcile with PITPK functioning
merely in a PtdIns supply role. At any rate, it is a
bit unsettling that yeast Sec14p substitutes for PITPK
in the priming and the TGN-derived vesicle forma-
tion assays [53,56]. The lack of speci¢city with regard
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to PITP source in these reconstitution assays suggest
that PITPs may act indirectly to render PtdIns
monomers better substrates for PtdIns-kinases. The
notion of an indirect participation by PITPK in stim-
ulation of phospholipid kinase activity is strength-
ened by the demonstration that both yeast and mam-
malian PITPs also stimulate the activity of p150
adapter protein-associated PI-3-kinase [62]. More
work is required before a con¢dent judgement can
be made regarding the mechanism and physiological
signi¢cance of PITP function in stimulated phospho-
inositide biosynthesis.
At this point, it is perhaps worthwhile to engage in
some speculation regarding PITPL function. This
polypeptide not only binds/transfers SM in addition
to PI and PC, but it also localizes to the mammalian
Golgi complex in vivo [63]. Since the Golgi complex
also represents a major site of SM synthesis in mam-
malian cells [9], PITPL exhibits the expected proper-
ties for a polypeptide that might coordinate PC and
SM availability/metabolism in Golgi membranes so
as to properly coordinate DAG and ceramide-regu-
lated signaling events. It is less likely that PITPK
plays such a role because it not only fails to recog-
nize SM as a binding/transfer substrate, but it local-
izes to the mammalian cytoplasm and nucleus [63].
Finally, recent studies with the Drosophila mela-
nogaster rdgB mutant and the vibrator mouse are
providing the ¢rst physiological clues to PITPK func-
tion in higher eukaryotes. Work from these systems
now indicates that inherited PITP insu⁄ciencies re-
sult, by unknown mechanisms, in speci¢c neurode-
generative diseases [64,65]. In the case of Drosophila,
PITP de¢ciency results in a light-enhanced retinal
degeneration, and inappropriate tra⁄cking of rho-
dopsin to the rhabdomere may contribute to the de-
generative process [64]. Mice with reduced PITPK
levels su¡er from a progressive ascending motor par-
alysis that ultimately results in early onset apnea and
death [65]. However, since there is as yet no evidence
for an associated Golgi dysfunction in either of these
inherited neurodegenerative diseases, the reader is
referred to the primary references for further details.
5.2. ARF proteins, phospholipase D and
phosphoinositide synthesis
Members of the ADP-ribosylation factor (ARF)
family are myristoylated low molecular weight
GTPases that play important roles in the execution
of vesicle budding events at a number of stages of the
secretory and endocytic pathways [2]. One particular
member of this family, ARF1, is required for the
assembly of the so-called COPI vesicle coat (also
termed coatomer) which is required for the genesis
of vesicles from the surface of Golgi membranes [2].
In addition, ARF1 potentiates assembly of clathrin-
coated vesicles on the mammalian TGN. The GTP-
bound form of ARF1 associates tightly with mem-
branes and e¡ects the recruitment of coat proteins to
Golgi membranes, while the GDP-bound form is not
membrane associated [2]. Thus, the ARF1 nucleotide
exchange reaction represents a critical point of regu-
lation in the coatomer assembly pathway. There is
strong evidence to indicate that phosphoinositides
are intimately involved in this regulation. The 47
kDa Arno protein is an ARF1 nucleotide exchange
factor (NEF) that binds PIP2 via a C-terminal pleck-
strin homology (PH) domain. The data indicate that
binding of PIP2 strongly stimulates the activity of
Arno as an ARF1 NEF, thereby identifying PIP2
as a physiologically attractive potentiator of at least
COP1 coat assembly [66].
Initial models of ARF1 function in COP1 coat
assembly posited ARF1 to be a stoichiometric con-
stituent of the coat complex [2]. Con£icting data
have more recently been obtained to indicate that
ARF1 acts in a catalytic fashion to potentiate
COP1 assembly [67]. In support of the latter view,
there is now strong evidence to indicate that the
GTP-bound form of ARF1 synergizes with PIP2 to
activate speci¢c isoforms of phospholipase D [68,69].
Phospholipase D (PLD) catalyzes the hydrolysis of
PtdCho to PtdOH and free choline, and PtdOH in
turn activates type 1 PtdIns-4-P 5-kinase that func-
tions to produce PIP2 [70]. On the basis of such
interwoven protein-phospholipid interactions, it has
been proposed that ARF1 and PLD cooperate in a
positive feedback ampli¢cation loop that generates
high local concentrations of both PtdOH and PIP2
([71]; see Fig. 3). This phospholipid microdomain
might be restricted to the actual vesicle that is being
formed from the Golgi membrane surface. Ulti-
mately, perhaps when the transport vesicle has been
released from the Golgi membrane of its birth and
has docked at the membrane to which it will fuse, the
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elevated vesicle membrane PtdOH and PIP2 levels
may e¡ect stimulation of a GTPase activating pro-
tein (GAP). This GAP in turn activates the ARF1
GTPase activity so that disassembly of the COP1
coat can occur as a prerequisite for the membrane
fusion event that follows (Fig. 3). Consistent with
this general scenario, it has been demonstrated that
the yeast Gcs1 protein is an ARF-GAP [72], and
Gcs1 shares considerable primary sequence homol-
ogy with a mammalian PtdIns-3,4,5-P3 binding pro-
tein (centaurin K) whose in vivo function remains
unelucidated [73]. A demonstration that either Gcs1
or centaurin K exhibits a phosphoinositide-regulated
GAP activity would lend further support for this
general paradigm.
There is little question that a strong case is now
being built around the concept that formation of
PtdOH is also necessary for the formation of at least
certain classes of mammalian protein transport
vesicles. Inhibition of PLD-mediated PtdOH forma-
tion by primary alcohols (which drive the formation
of Ptd-alcohols at the expense of PtdOH formation)
inhibits the formation of both Golgi- and ER-
derived protein transport vesicles [67,74]. At least
the latter block is overcome by introduction of
PtdOH, in the form of liposomes, into the vesicle
budding reaction [74]. Consistent with these ¢ndings,
it has also been demonstrated that high levels of
bacterial phospholipase D (which also produces
PtdOH at the expense of PtdCho) can bypass the
ARF1 requirement for assembly of COP1 coats in
vitro [67].
Very recently, additional evidence has been ob-
tained to suggest that GTP hydrolysis by ARF1, a
prerequisite for disassembly of the COP1 coat from
the docked transport vesicle, is also a lipid-regulated
reaction. Both the binding of ARF1-GAP to lipid
vesicles and its activity in stimulating ARF1-medi-
ated GTP hydrolysis is potentiated by diacylglycerols
with monounsaturated acyl chains [75]. Since such
diacylglycerols are downstream products of PLD-
mediated PtdCho turnover, and PtdCho inhibits
ARF1-GAP binding to lipid vesicles [75], these
data raise the intriguing possibility that PtdCho-de-
rived DAG production provides a physiologically
relevant feedback mechanism that downregulates
ARF1-GTP-mediated recruitment of the COP1 coat
to membranes. Such a downregulation could readily
be envisioned to stimulate the uncoating of COP1-
coated vesicles, and ARF-GAP would in e¡ect rep-
resent a DAG ‘sensor’ in this Golgi tra⁄cking reac-
tion. Thus, the data now favor a catalytic cascade
involving ARF1, PLD and phosphoinositide kinases
in both ARF1-mediated coatomer assembly and dis-
assembly reactions. In this cascade, lipids di¡eren-
tially regulate both the ARF1 nucleotide exchange
and GTP hydrolysis reactions that promote COP1
coat assembly and disassembly, respectively.
At this point, it is worthwhile to make several
points concerning the potential of the basic tenets
of the mammalian ARF-phospholipid connection in-
tersecting with the Sec14p-DAG connection in yeast.
What justi¢es this discussion is a previous specula-
tion that yeast and mammalian PITPs enter this pic-
ture at the level of stimulating synthesis of PIP2
Fig. 3. An ARF-PLD-PITP pathway for formation of Golgi-de-
rived protein transport vesicles. Mammalian PITP is suggested
to drive phosphoinositide synthesis, an action that manifests it-
self in activation of guanine nucleotide exchange factor (GEF)-
mediated activation of ARF. The activated ARF (ARFVGTP)
cooperates with PIP2 in stimulation of PLD activity. PLD cata-
lyzes hydrolysis of phosphatidylcholine (PC) to phosphatidic
acid (PA) and free choline. PA in turn activates PI-kinases
that, in concert with PITP, generate a PIP2 pool that somehow
stimulates vesicle budding. The PIP2 pool can also act as a pos-
itive feedback mechanism to further stimulate ARF and PLD
activation. This would result in even greater rates of PIP2 pro-
duction. Negative feedback regulation can potentially come
from conversion of the PA generated by PLD action to mono-
unsaturated diacylglycerols (DAG). Shunting of PA to DAG
would likely involve the action of PA phosphohydrolases. This
DAG pool may activate the ARF-coupled GTPase activating
protein (GAP) so as to inactivate ARF by driving it into the
ARFVGDP form. This model demands that PLD be as essen-
tial as ARF and PITP for the vesicle budding reaction. Details
are discussed in the text.
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pools that act to stimulate ARF-NEF activity and to
recruit vesicle coat proteins [76]. While that specula-
tion is not supported by many of the functional data
obtained from the yeast system [15,39,42], another
body of work has been o¡ered as evidence in favor.
Data collected from double mutant yeast strains that
are defective both in Sec14p function and CDP-chol-
ine pathway activity indicate Sec14p-de¢cient yeast
experience two signi¢cant physiological abnormal-
ities of interest: (i) increased rates of phospholipase
D (PLD)-mediated PtdCho turnover (via the activity
of the yeast PLD1/SPO14 gene product), and (ii)
altered transcriptional regulation of phospholipid
biosynthetic genes [77]. Based on such data, it has
been proposed that increased production of PtdOH
e¡ects the ‘bypass Sec14p’ phenotype of mutations
that block PtdCho synthesis via the CDP-choline
pathway (see Section 4.2; Fig. 2). By this view,
PtdOH is the key phospholipid that is required for
Sec14p-mediated Golgi secretory function [77]. It is
also proposed that this requirement provides evi-
dence for the involvement of Sec14p in stimulating
an ARF1-PLD pathway for Golgi secretory function
in yeast [77]. Although the basic tenet of this pro-
posal fully agrees with the previously proposed con-
cept that Sec14p protects the integrity of a phospho-
lipid precursor pool in Golgi membranes that is
required for Golgi secretory vesicle genesis
[15,39,43,48], we nonetheless do not presently favor
the interpretation that Sec14p interacts with ARF1
and Pld1p in stimulating formation of Golgi-derived
secretory vesicles in yeast. We list ¢ve reasons to
support this position.
First, more direct data indicate that Sec14p-de-
pendent Golgi function responds to DAG levels
and that shunting of DAG to PtdOH is detrimental
to Sec14p-mediated Golgi secretory function in yeast
[39]. Thus, PtdOH is not the key precursor that reg-
ulates Sec14p-dependent Golgi function. Second,
yeast PIP2-activated PLD activity (elaborated solely
by the yeast PLD1/SPO14 gene product [78]), in
marked contrast to the mammalian case, is not
ARF1-activated (J. Engebrecht, personal communi-
cation). As a result, the notion that yeast and mam-
malian PLDs share the property of being subject to
activation by both PIP2 and ARF1 is not supported
by present data. Third, the fact that the yeast PLD1/
SPO14 gene product (Pld1p) is completely dispensa-
ble for Golgi secretory function is patently inconsis-
tent with an ARF1-Pld1p pathway for Golgi secre-
tory vesicle biogenesis, especially since there are no
other PIP2-activated PLDs in yeast [78]. A model
that proposes that ARF1 stimulates Pld1p activity
that promotes Sec14p-mediated generation of an es-
sential PIP2 pool must also demand that Pld1p
would itself be essential for Golgi secretory function
(see Fig. 3). We emphasize that yeast have two ARF
genes (ARF1 and ARF2 ; ARF1 is the major ARF
isoform), with either one being su⁄cient to ful¢ll the
essential role ARF plays in promoting yeast Golgi
function [79,80]. That Pld1p activity is entirely non-
essential for yeast viability [78] and Golgi secretory
function (our unpublished data) presents a dramatic
challenge to a Sec14p-ARF1-Pld1p pathway for Gol-
gi function in yeast. It should be emphasized that
yeast Pld1p is required for proper execution of a
non-vegetative developmental program (i.e. sporula-
tion), and this activity couples PtdCho hydrolysis to
formation of spore membrane during meiosis [81].
Fourth, while disruption of the PLD1 gene does ab-
rogate the ‘bypass Sec14p’ phenotype associated with
mutations that block the activity of the CDP-choline
pathway in yeast (manuscript in preparation), that
¢nding does not reveal why. We propose that
Pld1p activity generates PtdOH that is subsequently
converted to DAG by the action of PtdOH phospho-
hydrolases. This issue is currently being addressed.
Fifth, the ¢rst execution point for yeast ARF1 is at
the level of the early Golgi complex, likely at the
level of protein retrieval from the Golgi to the endo-
plasmic reticulum (reviewed in [82]), while the essen-
tial Sec14p execution point resides at the level of
protein exit from the Golgi complex (see Section
4). Thus, the requirements for ARF1 and Sec14p
function in yeast Golgi function do not coincide in
the expected manner.
Finally, we note that a connection between ‘bypass
Sec14p’ mutations and altered regulation of phos-
pholipid biosynthetic genes had been previously
noted [43] but, at least in that case, it had been
shown that the ‘bypass Sec14p’ phenotypes and the
transcriptional e¡ects are not directly related [43].
We suspect that the pleiotropic e¡ects reported in
[77] similarly fail to reveal direct relationships be-
tween the biochemistry that underlies Sec14p-medi-
ated Golgi function, Pld1p/Spo14p-mediated PtdCho
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turnover, and transcriptional regulation of phospho-
lipid biosynthetic genes.
5.3. PtdIns 3-kinase and Golgi function
The yeast VPS34 gene is required for the e⁄cient
late Golgi-mediated sorting of soluble proteins des-
tined for the vacuole from those fated to transit to
the plasma membrane [83]. This gene encodes for the
major, if not the sole, PtdIns-3 kinase of yeast, and
the lipid kinase activity is essential for Vps34 func-
tion in vivo [83,84]. Vps34 is found in a complex with
Vps15, a serine-threonine kinase that associates with
Golgi and endosomal membranes, and functional
Vps15 is required for activation of the Vps34 lipid
kinase activity [84,85]. It has been proposed that
Vps15 serves as the address tag which recruits
Vps34 to the site of genesis of the vesicles that ferry
vacuolar hydrolases to their ultimate destination.
How Vps34 functions to stimulate this process is
unclear. PtdIns-3-P exhibits a large headgroup and,
on the basis of the principles set forth in the bilayer-
couple hypothesis [86], it has been suggested that
restriction of elevated concentrations of this phos-
phoinositide to a microdomain might impose positive
curvature to the Golgi microdomain so as to facili-
tate vesicle budding [51]. Alternatively, a microdo-
main rich in PtdIns-3-P might form a sca¡old upon
which the appropriate vesicle coat proteins would
assemble in a reaction that ultimately drives vesicle
budding. That PtdIns-3-P is the physiologically im-
portant phosphoinositide for these sorting reactions
remains unclear, however. Recently, the existence of
PtdIns-3,5-P2 has been reported in yeast, and syn-
thesis of this novel phosphoinositide is both Vps34-
dependent and induced by osmotic stress [87]. Given
the vacuolar sorting defects observed by genetic in-
activation of the FAB1 PtdIns-4-phosphate 5-kinase
in yeast [88], it is entirely plausible that the Vps34
requirement for vacuolar protein sorting from the
Golgi complex is mediated through PtdIns-3,5-P2
and not PtdIns-3-P.
Finally, the 3-phosphorylated phosphoinositide
paradigm for Golgi-lysosome/vacuole sorting reac-
tions may not be limited to yeast. A Vps34-Vps15-
like complex has been identi¢ed in mammalian cells
and proposed to facilitate TGN-lysosomal tra⁄cking
[89], an intracellular membrane tra⁄cking pathway
that based upon pharmacological criteria requires
PtdIns-3-kinase activity for e⁄cient function [90]. A
novel 85 kDa cytosolic complex (p62cplx), consisting
of a 25 kDa GTPase and a 62 kDa regulatory sub-
unit of a PI-3-kinase, has also been recently charac-
terized on the basis of its ability to stimulate the
budding of polymeric IgA receptor-containing secre-
tory vesicles from hepatocyte TGN [91,92]. The
p62cplx-associated PI-3-kinase activity is stimulated
by GTP and this activity, by pharmacological crite-
ria, plays a direct role in formation of TGN-derived
exocytic vesicles [93].
5.4. Conclusions
Recent events clearly indicate that the next several
years in the membrane transport ¢eld will witness an
ever increasing interest in the lipid binding properties
of components of the secretory and endosomal
vesicle tra⁄cking machineries. In addition to the
cast of characters discussed in this chapter, phospho-
lipid metabolizing enzymes such as type II inositol-5-
phosphatases of the synaptojanin family are already
coming to the fore as potential regulators of mem-
brane tra⁄cking events that operate through modu-
lation of phosphoinositide levels [51,93]. Indeed, the
type II OCRL protein that is defective in human
oculocerebrorenal Lowe’s syndrome patients may
perform such a function at the level of the Golgi
complex [94]. Many of these lipid phosphatases har-
bor N-terminal extensions that share signi¢cant pri-
mary sequence homology with the Sac1 protein of
yeast Golgi whose dysfunction elevates Golgi DAG
levels via altered PtdIns and sphingolipid metabolism
and e¡ects bypass of the essential Sec14p require-
ment for Golgi secretory function [37,39,95]. The
Sac1 protein family is conserved from yeast to mam-
mals, and there are very few clues as to how these
proteins regulate PtdIns metabolism. In addition, ce-
ramide levels have recently been linked to the steady-
state retention of at least one protein in cis-Golgi
membranes [96], and unusual phospholipids such
as semilysobisphosphatidic acid also likely play im-
portant roles in supporting Golgi structure/function
[97]. Thus, the impressive recent advances notwith-
standing, it is clear that we have yet much to learn
regarding how lipids interface with Golgi function in
cells.
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